NCT00614757View on ClinicalTrials.gov

Insulin Resistance Study

NASuspendedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Insulin ResistanceMetabolic Syndrome x
Interventions
DRUG

N-acetylcysteine 20% 4ml

N-acetylcysteine 20% 4ml

DRUG

N-acetylcysteine 20% in 4 ml

N-acetylcysteine 20% in 4 ml

Trial Locations (1)

64128

Kansas City VA Medical Center, Kansas City

Sponsors
All Listed Sponsors
lead

Midwest Biomedical Research Foundation

OTHER

NCT00614757 - Insulin Resistance Study | Biotech Hunter | Biotech Hunter